Doximity, Inc.

Doximity, Inc.

DOCS
Doximity, Inc.US flagNew York Stock Exchange
27.93
USD
-0.57
- -
5.22BMarket Cap
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
0.57
0.77
1.16
2.1
2.17
2.5
3.05
3.45
3.53
Basic EPS, GAAP
0.05
0.2
0.28
0.95
0.58
0.78
1.19
1.05
0.9
Free Cash Flow per Basic Share
0.1
0.15
0.44
0.74
0.9
0.94
1.43
1.7
1.6
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
Book Value per Share
- -
0.01
0.37
4.57
4.98
4.83
5.73
5.19
5.09
Tangible Book Value per Share
- -
- -
0.21
4.43
4.47
4.32
5.25
4.54
4.44
Basic Weighted Avg Shares
151
151
178
163
193
190
187
187
186
Sales/Revenue/Turnover
86
116
207
344
419
475
570
645
656
Operating Margin (%)
8.08
19.04
25.76
33.05
29.86
36.14
40.34
33.33
29.6
Depreciation Expense
1
1
4
5
10
10
11
14
16
Net Income, GAAP
8
30
50
155
113
148
223
196
167
Effective Tax Rate (%)
1.24
- -
13.08
- -
15.27
20.31
15.32
21.58
26.16
Profit Margin (%)
9.14
25.55
24.27
45.05
26.92
31.04
39.13
30.4
25.48
Working Capital
- -
67
107
793
836
766
932
789
764
LT Debt
- -
- -
- -
- -
14
12
10
8
8
Total Equity
- -
1
67
879
966
901
1,083
951
916
Return on Invested Capital (%)
- -
- -
132.61
- -
11.38
14.33
19.27
16.36
14.48
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
5,235.39
147.94
32.75
12.23
15.81
22.5
19.28
17.21

Capital Structure

FRC

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
2
2
2
LT Borrowings
- -
- -
- -
LT Finance Leases
9
8
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
185
183
180
Market Capitalization
8,191
4,265
3,730

Working Capital

FRC

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
993
944
914
Cash, Cash Equivalents & STI
735
749
688
Accounts Receivable, Net
157
145
178
Inventories
- -
- -
- -
Total Current Liabilities
150
155
150
Payables & Accruals
67
32
33
ST Debt
2
2
2
Deferred Revenue
66
106
109

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
245.52%
-12.17%
Free Cash Flow
- -
33.83%
19.03%
Net Income, GAAP
- -
50.21%
-12.16%
Sales/Revenue/Turnover
- -
26.9%
13.05%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
127
137
169
138
570
2026
146
169
185
145
645
2027
157
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
0.22
0.24
0.4
0.33
1.19
2026
0.28
0.33
0.33
0.1
1.05
2027
0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
2027
- -
- -
- -
- -
- -

Company Description

CEO
Jeffrey A. Tangney
Full Time Employees
880
Sector
Healthcare
Industry
Medical - Healthcare Information Services
Address
500, 3rd Street San Francisco CA United States of America 94107
IPO Date
Jun 24, 2021
Business
I will refine the search specifically for latest major company changes for Doximity, Inc. to find accurate and recent updates.

Company News

  • ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

  • ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS

  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit

  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit

  • ROSEN, LEADING INVESTOR COUNSEL, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - DOCS

  • Kaplan Fox Announces a Securities Class Action Filed Against Doximity, Inc. (DOCS) - Lead Plaintiff Deadline is November 16, 2026

  • DOCS Investors Have Opportunity to Lead Doximity, Inc. Securities Fraud Lawsuit with SBS Law

  • Robbins LLP Urges DOCS Stockholders Who Lost Money Investing in Doximity, Inc. to Contact the Firm for Information About Leading the Class Action Lawsuit

  • Bronstein, Gewirtz & Grossman LLC Urges Doximity, Inc. Investors to Act: Class Action Filed Alleging Investor Harm

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines - DOCS

  • INVESTOR ALERT: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline, Robbins Geller Rudman & Dowd LLP Announces - DOCS

  • ROSEN, TOP-RANKED TRIAL ATTORNEYS, Encourages Doximity, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – DOCS

  • Doximity, Inc. (DOCS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit

  • DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class Action - Contact the Firm

  • DOCS UPCOMING DEADLINE: Levi & Korsinsky Alerts Doximity, Inc. Stockholders of Securities Class Action - Contact the Firm

  • Kaplan Fox Alerts Investors of Doximity, Inc. (DOCS) with Significant Losses to a Securities Class Action Deadline on November 16, 2026

  • DOXIMITY, INC. (DOCS) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Doximity, Inc. Investors of Upcoming Deadline

  • DOCS ALERT: Doximity, Inc. Investors with Substantial Losses May Seek to Lead Class Action Lawsuit Before November 16, 2026 Deadline

  • Doximity (DOCS) Gains As Market Dips: What You Should Know

  • INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Doximity, Inc. of Class Action Lawsuit and Upcoming Deadlines – DOCS